Dennis Hom
2022
In 2022, Dennis Hom earned a total compensation of $466.9K as Former Chief Financial Officer at Sagimet Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $109,351 |
|---|---|
| Salary | $357,473 |
| Other | $68 |
| Total | $466,892 |
Hom received $357.5K in salary, accounting for 77% of the total pay in 2022.
Hom also received $109.4K in non-equity incentive plan and $68 in other compensation.
Rankings
In 2022, Dennis Hom's compensation ranked 4,464th out of 5,760 executives tracked by ExecPay. In other words, Hom earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,464 out of 5,760 | 23rd |
Division Manufacturing | 2,514 out of 3,136 | 20th |
Major group Chemicals And Allied Products | 1,209 out of 1,422 | 15th |
Industry group Drugs | 1,136 out of 1,323 | 14th |
Industry Pharmaceutical Preparations | 829 out of 969 | 14th |
Source: SEC filing on April 18, 2024.
Hom's colleagues
We found three more compensation records of executives who worked with Dennis Hom at Sagimet Biosciences in 2022.